Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic predictors in colorectal cancer

G Lindmark1, B Gerdin, L Påhlman

  • 1Department of Surgery, Uppsala, Sweden.

Diseases of the Colon and Rectum
|December 1, 1994
PubMed
Summary

The Dukes stage remains the best colorectal cancer prognostic predictor. However, tissue polypeptide antigen offers additional independent prognostic information for personalized patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long term health-related quality of life after burns is strongly dependent on pre-existing disease and psychosocial issues and less due to the burn itself.

Burns : journal of the International Society for Burn Injuries·2013
Same author

Inhibition of connective tissue growth factor/CCN2 expression in human dermal fibroblasts by interleukin-1alpha and beta.

Journal of cellular biochemistry·2010
Same author

Prediction of patient satisfaction with care one year after burn.

Burns : journal of the International Society for Burn Injuries·2008
Same author

Injury-related fear-avoidance, neuroticism and burn-specific health.

Burns : journal of the International Society for Burn Injuries·2006
Same author

Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil.

Annals of oncology : official journal of the European Society for Medical Oncology·2005
Same author

Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination.

European journal of cancer (Oxford, England : 1990)·2005

Area of Science:

  • Oncology
  • Cancer Research
  • Clinical Pathology

Background:

  • Accurate prognostic predictors are crucial for tailoring colorectal cancer treatment and follow-up strategies.
  • The current Dukes staging system, while valuable, may not fully capture all prognostic nuances.

Purpose of the Study:

  • To identify prognostic predictors of colorectal cancer survival beyond the established Dukes stage.
  • To evaluate the independent prognostic value of various clinical, histopathologic, cellular, and serologic factors.

Main Methods:

  • Survival analysis was performed on 212 patients undergoing surgery for colorectal cancer.
  • Numerous clinical, histopathologic, cellular, and serologic variables were assessed.
  • Multivariate analysis was employed to determine independent predictors of survival.

Main Results:

  • The Dukes stage was the most significant prognostic variable.
  • Erythrocyte sedimentation rate, leukocyte blood count, alkaline phosphatase, aspartate aminotransferase, six serum tumor markers, vascularity, and age were associated with survival.
  • In multivariate analysis, tumor stage, tissue polypeptide antigen, and age remained significant predictors.

Conclusions:

  • While Dukes stage is the primary prognostic indicator, tissue polypeptide antigen provides independent prognostic information.
  • These findings can aid in refining risk stratification and personalized management for colorectal cancer patients.

Related Experiment Videos